ALLMedicine™ Anti-ro Antibody Center
Research & Reviews 15 results
The Journal of the Royal College of Physicians of Edinburgh; Azharudeen M, Thabah MM et. al.
Jan 21st, 2021 - The QT interval a marker of ventricular depolarization and repolarization is reported to be prolonged in some proportion of patients with systemic lupus erythematosus (SLE). We studied electrocardiographic (ECG) abnormalities, in particular QT int...
Annals of the Rheumatic Diseases; Baer AN, Gottenberg JE et. al.
Nov 11th, 2020 - To evaluate efficacy and safety of abatacept in adults with active primary Sjögren's syndrome (pSS) in a phase III, randomised, double-blind, placebo-controlled trial. Eligible patients (moderate-to-severe pSS [2016 ACR/European League Against Rhe...
Dermatology Online Journal; Gray T, Segars K et. al.
Feb 12th, 2020 - A 66-year-old man presented to the outpatient dermatology clinic with a chief complaint of a pruritic rash on his upper trunk and proximal upper extremities, which had been present for three weeks. Upon examination, he was found to have an erythem...
International Journal of Rheumatic Diseases; Kim SK, Choe JY et. al.
Nov 7th, 2018 - The clinical importance of the anti-Ro antibody has not been completely understood. This study investigated identification of the association between mortality and clinical features in patients with autoimmune rheumatic diseases and detectable ant...
Journal of the American College of Cardiology; Cuneo BF, Sonesson SE et. al.
Oct 13th, 2018 - Fetal atrioventricular block (AVB) occurs in 2% to 4% of anti-Ro antibody-positive pregnancies and can develop in <24 h. Only rarely has standard fetal heart rate surveillance detected AVB in time for effective treatment. Outcome of anti-Ro pregna...
News 2 results
Jan 19th, 2019 - Risk factors for scleroderma renal crisis (SRC) include cold exposure, steroid use, dehydration, rapid progression of skin disease, tendon friction rubs, anti-RNA polymerase III antibodies, and pregnancy. A new study examines the risk factors for ...
Feb 18th, 2014 - SNOWMASS, COLO. – The prospect of preventing fetal heart block from neonatal lupus by using hydroxychloroquine to treat women with systemic lupus erythematosus and other anti-Ro antibody-positive rheumatologic diseases throughout pregnancy is draw.